Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machines

Late-stage or post-market identification of adverse drug reactions (ADRs) is a significant public health issue and a source of major economic liability for drug development. Thus, reliable in silico screening of drug candidates for possible ADRs would be advantageous. In this work, we introduce a co...

Ausführliche Beschreibung